VGKC Antibody CSF Test: Booking, Price, and Results
About VGKC Antibody CSF Test: Booking, Price, and Results
| Field | Value |
|---|---|
| Also Known As | VGKC Ab CSF, Voltage-Gated Potassium Channel Antibody CSF, Anti-VGKC Antibody CSF, Potassium Channel Antibody CSF |
| Sample Type | Cerebrospinal fluid (CSF), collected via lumbar puncture (spinal tap) |
| Fasting Required | No fasting required |
| Report Time | 7 to 14 days (processed at a specialised reference laboratory) |
| Recommended For | Adults and children of any gender when an autoimmune neurological condition is clinically suspected |
| Price | Starting at ₹10,000 |
What Is a VGKC Antibody CSF Test?
The VGKC Antibody CSF test detects antibodies against the voltage-gated potassium channel complex in cerebrospinal fluid (CSF), the fluid that surrounds the brain and spinal cord. It is also known as the Voltage-Gated Potassium Channel Antibody CSF test. Doctors order this test when a patient shows signs of an autoimmune neurological condition, meaning the immune system is mistakenly attacking the nervous system. The sample is collected from the spinal canal through a procedure called a lumbar puncture, or spinal tap.
What Does a VGKC Antibody CSF Test Measure?
This test looks for antibodies targeting the VGKC receptor complex and two closely associated proteins. Each of these markers is linked to specific neurological conditions.
The table below summarises the three key markers this test evaluates:
| Marker | What It Is | Why It Matters |
|---|---|---|
| VGKC-complex antibodies | Antibodies against the potassium channel complex | Linked to neuromuscular weakness, limbic encephalitis, and paraneoplastic syndromes |
| LGI1 antibodies | Antibodies against leucine-rich glioma inactivated 1 protein, which organises connections between nerve cells | Strongly associated with limbic encephalitis and faciobrachial dystonic seizures |
| CASPR2 antibodies | Antibodies against contactin-associated protein 2, found in the hippocampus and at nerve junctions | Associated with overactive nerves, Morvan syndrome, and thymoma (a tumour of the thymus gland) |
Why Is a VGKC Antibody CSF Test Done?
This test is ordered when a neurologist suspects the nervous system is being affected by an autoimmune process. The results help narrow down the diagnosis and guide further investigation.
Common Symptoms That May Require This Test
Several neurological and behavioural symptoms may prompt a doctor to request this test. The following are the most common reasons this test is ordered:
- Memory problems or confusion
- Seizures or episodes of abnormal body movements
- Psychiatric symptoms such as hallucinations or sudden behavioural changes
- Excessive drowsiness or reduced alertness
- Sudden involuntary muscle jerks (myoclonus)
- Severe or unusual insomnia
- Painful muscle cramps or visible muscle twitching (myokymia)
Conditions This Test Can Help Detect
The VGKC Antibody CSF test can support the diagnosis of the following conditions:
- Limbic encephalitis, an autoimmune inflammation of the brain's limbic system, which controls memory and emotions
- Acquired neuromyotonia (also called Isaacs' syndrome), a rare disorder causing continuous muscle activity
- Morvan syndrome, a complex neurological disorder involving overactivity of the central, autonomic, and peripheral nervous systems
- Faciobrachial dystonic seizures, brief repetitive movements affecting the face and arm, particularly linked to LGI1 antibodies
- Paraneoplastic syndromes, nerve problems associated with underlying cancers such as thymoma or small cell lung cancer
VGKC Antibody CSF Test for Chronic Disease Monitoring
Once a patient tests positive for VGKC, LGI1, or CASPR2 antibodies, repeat testing may be used to track response to treatment. Immunotherapy or plasmapheresis (a procedure that filters antibodies from the blood) is typically associated with a reduction in antibody levels. Monitoring these levels over time helps the treating neurologist assess whether the chosen approach is working.
How to Prepare and What to Expect
Since this test uses CSF rather than blood, the preparation and procedure differ from a routine blood test. The steps below explain what to expect.
Do You Need to Fast?
No fasting is required for this test. You may eat and drink normally before your appointment.
Practical Tips Before Your Test
A few steps before the procedure can help it go smoothly:
- Tell your doctor about all medications you are taking, particularly aspirin or blood-thinning medicines.
- If your doctor suspects increased pressure in the brain, you may need a CT or MRI scan before the lumbar puncture is performed.
- Wear loose, comfortable clothing on the day of the procedure.
- Plan to rest for several hours after the procedure to allow the puncture site to seal properly.
Step-by-Step Procedure
Here is what typically happens during a lumbar puncture for CSF collection:
- You will be asked to lie on your side or sit and lean forward so that the lower back is accessible and the spine is slightly curved.
- The skin on your lower back is cleaned, and a local anaesthetic is injected to numb the area completely.
- Once the area is numb, a hollow needle is gently inserted between two vertebrae in the lower spine into the fluid-filled space surrounding the spinal cord.
- A small sample of CSF, typically between 1 and 10 millilitres, is drawn off into sterile vials.
- The needle is removed, the area is cleaned, and a small bandage is applied over the site.
- The procedure usually takes around 30 minutes. The sample is then labelled and sent to a reference laboratory for analysis.
Factors That Can Affect Accuracy
Several factors may influence the reliability of the test result:
- Poor quality of CSF sample at the time of collection
- Improper storage or transport (the sample must be kept refrigerated or frozen)
- Recent immunotherapy or plasmapheresis, which can lower antibody levels in the CSF
- Concurrent infections or other autoimmune conditions
- The presence of VGKC-complex antibodies that are negative for both LGI1 and CASPR2, since the clinical significance of these "double-negative" results is limited
Understanding Your VGKC Antibody CSF Test Results
Results from this test should always be reviewed with a neurologist alongside your clinical history and other investigations. The table below provides a general guide to result interpretation.
| Parameter | Negative | Equivocal | Positive | Unit |
|---|---|---|---|---|
| VGKC-complex antibodies | 0 to 69 | 70 to 130 | Above 130 | pmol/L |
Higher titres, generally at or above 250 pmol/L, are more commonly associated with well-defined conditions such as limbic encephalitis or neuromyotonia. Low-level positive results, particularly those negative for both LGI1 and CASPR2, may not have a clear clinical meaning and require careful interpretation.
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
Results During Special Conditions
Certain conditions and circumstances can affect how results are interpreted:
- Low blood sodium (hyponatraemia) occurs in up to 60% of patients with anti-LGI1 encephalitis and may influence the overall clinical picture.
- Recent immunotherapy or plasmapheresis can reduce antibody levels, potentially affecting the result.
- In some cases of encephalitis, the CSF may also show elevated protein or raised immunoglobulin G (IgG) levels.
- Concurrent infections or other autoimmune conditions may produce overlapping findings.
How to Maintain Healthy Levels
Unlike routine blood markers, VGKC antibody levels are not influenced by diet or lifestyle choices. The following general points are worth noting:
- Early attention to symptoms such as new memory problems, unexplained seizures, or unusual behavioural changes is important; prompt medical review is advisable.
- Regular follow-up with a neurologist is essential for anyone who has tested positive, as monitoring antibody levels guides ongoing care.
- Discuss any changes in symptoms or medications with your doctor before your next review.
Lupin Diagnostics VGKC Antibody CSF Test Price
The VGKC Antibody CSF test starts at approximately ₹10,000 and requires a visit to a Lupin Diagnostics centre. Home collection is not available for this test, as the sample must be collected by a trained professional in a clinical setting.
| City | Approximate Price (₹) |
|---|---|
| Mumbai | ₹10,000 |
| Bengaluru | ₹10,000 |
| Hyderabad | ₹10,000 |
| Chennai | ₹10,000 |
| Kolkata | ₹10,000 |
| Pune | ₹10,000 |
Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
Follow these steps to book your test:
- Select the test on the Lupin Diagnostics website.
- Choose your city and preferred centre location.
- Visit the centre at your scheduled time for sample collection.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Frequently Asked Questions
The VGKC Antibody CSF test helps identify autoimmune conditions affecting the brain and nervous system, such as autoimmune encephalitis, neuromyotonia, and Morvan syndrome. It does this by detecting specific antibodies in the cerebrospinal fluid. Your neurologist will use the result alongside your symptoms and other tests to reach a diagnosis.
CSF is in direct contact with the brain and spinal cord, so antibodies produced within the nervous system may appear in the CSF before or at higher levels than they do in blood. Testing CSF can therefore be more informative for neurological conditions. The Voltage-Gated Potassium Channel Antibody CSF test is specifically designed to detect these central nervous system antibodies.
The area is numbed with a local anaesthetic before the needle is inserted, so most patients feel only a sensation of pressure rather than sharp pain. Staying in the required position for the procedure can be mildly uncomfortable. A headache after the procedure is possible but usually settles within a few days with rest.
A positive result is associated with several neurological conditions, including limbic encephalitis, Isaacs' syndrome (neuromyotonia), faciobrachial dystonic seizures, and Morvan syndrome. Additional tests for the specific antibodies LGI1 and CASPR2 are usually ordered to clarify the diagnosis.
In some cases, yes. Studies have found that a notable proportion of patients with VGKC-complex antibodies also have an underlying malignancy, including thymoma or small-cell lung cancer. If your result is positive, your doctor may recommend tumour screening as part of the follow-up investigation.
A negative result suggests there is no detectable antibody-mediated autoimmune neurological process. However, a negative result does not completely exclude the diagnosis, as not all antigens within the VGKC complex have been identified. Your neurologist will consider the result together with your clinical presentation.
VGKC Antibody CSF Test: Booking, Price, and Results
